Myositis Interstitial Lung Disease and Autoantibodies

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2023 Jun 29

PMID 37384043

Authors

Shire Chaudhry

Lisa Christopher-Stine

Affiliations

Soon will be listed here.

Abstract

The aim of this review is to examine and evaluate published literature associated with idiopathic inflammatory myopathies (IIM) and interstitial lung disease (ILD) based on myositis specific autoantibodies (MSA) and the potential clinical significance of each autoantibody subtype for the practicing clinician. The review is a comprehensive search of literature published in PubMed from the year 2005 and onward coinciding with the surge in the discovery of new MSAs. Additionally, we comment on recommended multidisciplinary longitudinal care practices for patients with IIM-ILD with regard to imaging and other testing. Treatment is not covered in this review.

Citing Articles

Myositis-Associated Interstitial Lung Disease: The Experience of a Tertiary Center.

Correia B, Campanilho-Marques R, Dourado E, Silva M, Silva A, Costa F J Clin Med. 2024; 13(20).

PMID: 39458035 PMC: 11508529. DOI: 10.3390/jcm13206085.

A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease.

Patel P, Marinock J, Ajmeri A, Brent L Int J Mol Sci. 2024; 25(8).

PMID: 38674039 PMC: 11050089. DOI: 10.3390/ijms25084453.

References

Albayda J, Pinal-Fernandez I, Huang W, Parks C, Paik J, Casciola-Rosen L . Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients. Arthritis Care Res (Hoboken). 2017; 69(11):1771-1776. PMC: 5509530. DOI: 10.1002/acr.23188. View

Cho S, Kim H, Myung J, Nam E, Jung S, Jang E . Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study. J Korean Med Sci. 2019; 34(8):e55. PMC: 6393764. DOI: 10.3346/jkms.2019.34.e55. View

Lhote R, Grenier P, Haroche J, Miyara M, Boussouar S, Mathian A . Characterization of Interstitial Lung Disease Associated With Anti-Ribonucleoprotein Antibodies. J Clin Rheumatol. 2019; 26(8):327-333. DOI: 10.1097/RHU.0000000000001127. View

Vojinovic T, Cavazzana I, Ceruti P, Fredi M, Modina D, Berlendis M . Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis. Clin Rev Allergy Immunol. 2020; 60(1):87-94. PMC: 7819919. DOI: 10.1007/s12016-020-08814-5. View

Wolstencroft P, Fiorentino D . Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies. Curr Rheumatol Rep. 2018; 20(5):28. DOI: 10.1007/s11926-018-0733-5. View

Anquetil C, Boyer O, Wesner N, Benveniste O, Allenbach Y . Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy. Autoimmun Rev. 2019; 18(3):223-230. DOI: 10.1016/j.autrev.2018.09.008. View

Kaul B, Cottin V, Collard H, Valenzuela C . Variability in Global Prevalence of Interstitial Lung Disease. Front Med (Lausanne). 2021; 8:751181. PMC: 8599270. DOI: 10.3389/fmed.2021.751181. View

DeWane M, Waldman R, Lu J . Dermatomyositis: Clinical features and pathogenesis. J Am Acad Dermatol. 2019; 82(2):267-281. DOI: 10.1016/j.jaad.2019.06.1309. View

Long K, Danoff S . Interstitial Lung Disease in Polymyositis and Dermatomyositis. Clin Chest Med. 2019; 40(3):561-572. DOI: 10.1016/j.ccm.2019.05.004. View

10.

Qureshi A, Brown D, Brent L . Anti-Signal Recognition Particle Antibody-Associated Severe Interstitial Lung Disease Requiring Lung Transplantation. Cureus. 2020; 12(5):e7962. PMC: 7273426. DOI: 10.7759/cureus.7962. View

11.

Rogers A, Chung L, Li S, Casciola-Rosen L, Fiorentino D . Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients. Arthritis Care Res (Hoboken). 2017; 69(12):1909-1914. PMC: 5529261. DOI: 10.1002/acr.23210. View

12.

Gossez M, Levesque M, Khouatra C, Cottin V, Garnier L, Fabien N . Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody. Eur Respir Rev. 2015; 24(136):370-2. PMC: 9487820. DOI: 10.1183/16000617.00006714. View

13.

Gomez G, Perez N, Braillard Poccard A, Gomez R, Costi A, Garcia M . Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology. Clin Rheumatol. 2021; 40(11):4473-4483. DOI: 10.1007/s10067-021-05797-2. View

14.

Ichimura Y, Matsushita T, Hamaguchi Y, Kaji K, Hasegawa M, Tanino Y . Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis. 2012; 71(5):710-3. DOI: 10.1136/annrheumdis-2011-200697. View

15.

FRAZIER A, Miller R . Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest. 1974; 65(4):403-7. DOI: 10.1378/chest.65.4.403. View

16.

Betteridge Z, Gunawardena H, Chinoy H, North J, Ollier W, Cooper R . Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Ann Rheum Dis. 2008; 68(10):1621-5. DOI: 10.1136/ard.2008.097162. View

17.

Yan T, Zhang X, Yang H, Sun W, Liu L, Du Y . Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody. Clin Rheumatol. 2021; 40(9):3695-3702. DOI: 10.1007/s10067-021-05667-x. View

18.

Yan T, Du Y, Sun W, Chen X, Wu Q, Ye Q . Interstitial lung disease in adult patients with anti-NXP2 antibody positivity: a multicentre 18-month follow-up study. Clin Exp Rheumatol. 2022; 41(2):247-253. DOI: 10.55563/clinexprheumatol/lqjx4h. View

19.

Chen Z, Cao M, Plana M, Liang J, Cai H, Kuwana M . Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res (Hoboken). 2013; 65(8):1316-24. DOI: 10.1002/acr.21985. View

20.

Shao C, Sun Y, Huang H, Zhang Z, Pan R, Xu K . Myositis specific antibodies are associated with isolated anti-Ro-52 associated interstitial lung disease. Rheumatology (Oxford). 2021; 61(3):1083-1091. DOI: 10.1093/rheumatology/keab488. View